Stephen Galli
Directeur/Bestuurslid bij ATOSSA THERAPEUTICS, INC.
Vermogen: 129 $ op 31-05-2024
Profiel
Stephen J.
Galli is currently an Independent Director at Atossa Therapeutics, Inc. since 2011.
He is also a Professor at Stanford University School of Medicine since 1999.
Additionally, he holds the position of President at the Association of Pathology Chairs.
Previously, he served as President of Collegium Internationale Allergologicum and the American Society for Investigative Pathology.
Dr. Galli obtained his doctorate degree from Harvard Medical School in 1973 and his undergraduate degree from Harvard College in 1968.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
15-03-2024 | 99 ( 0.00% ) | 129 $ | 31-05-2024 |
Actieve functies van Stephen Galli
Bedrijven | Functie | Begin |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-07-2011 |
Stanford University School of Medicine | Corporate Officer/Principal | 01-02-1999 |
Association of Pathology Chairs | President | - |
Eerdere bekende functies van Stephen Galli
Bedrijven | Functie | Einde |
---|---|---|
Collegium Internationale Allergologicum | President | - |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | President | - |
Opleiding van Stephen Galli
Harvard College | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ATOSSA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Health Technology |
Collegium Internationale Allergologicum | |
Association of Pathology Chairs |